<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0238615.ref018">
 <label>18</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Monto</surname>
   <given-names>AS</given-names>
  </name>, 
  <name>
   <surname>Fleming</surname>
   <given-names>DM</given-names>
  </name>, 
  <name>
   <surname>Henry</surname>
   <given-names>D</given-names>
  </name>, 
  <name>
   <surname>de Groot</surname>
   <given-names>R</given-names>
  </name>, 
  <name>
   <surname>Makela</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Klein</surname>
   <given-names>T</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections</article-title>. 
  <source>The Journal of infectious diseases</source>. 
  <year>1999</year>;
  <volume>180</volume>(
  <issue>2</issue>):
  <fpage>254</fpage>â€“
  <lpage>61</lpage>. Epub 1999/07/09. 
  <pub-id pub-id-type="doi">10.1086/314904</pub-id> .
  <?supplied-pmid 10395837?>
  <pub-id pub-id-type="pmid">10395837</pub-id>
 </mixed-citation>
</ref>
